BioRestorative Therapies's market cap is currently ―. The company's EPS TTM is $-3.536; its P/E ratio is -0.39; BioRestorative Therapies is scheduled to report earnings on May 15, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 30.70K	$ 64.50K	$ 31.30K	$ 3.70K	$ 29.00K
Gross Profit	$ 30.70K	$ 64.50K	$ 31.30K	$ 3.70K	-
EBIT	$ -3.15M	$ -3.08M	$ 5.77M	$ -4.56M	$ -4.63M
EBITDA	$ -3.11M	$ -3.04M	$ 5.80M	$ -4.53M	$ -4.60M
Net Income Common Stockholders	$ -2.93M	$ -2.98M	$ 5.75M	$ -4.35M	$ -4.66M
Balance Sheet	-
Cash Cash Equivalents And Short Term Investments	$ 12.24M	$ 11.62M	$ 12.37M	$ 14.75M	$ 16.49M
Total Assets	$ 13.80M	$ 13.30M	$ 14.08M	$ 16.43M	$ 17.92M
Total Debt	$ 198.72K	$ 234.06K	$ 268.36K	$ 301.64K	$ 332.75K
Net Debt	$ -12.04M	$ -11.38M	$ -12.11M	$ -14.45M	$ -16.15M
Total Liabilities	$ 975.03K	$ 896.43K	$ 593.93K	$ 602.62K	$ 915.90K
Stockholders Equity	$ 12.83M	$ 12.40M	$ 13.49M	$ 15.83M	$ 17.00M
Cash Flow	-
Free Cash Flow	$ -1.21M	$ -1.23M	$ -2.36M	$ -1.79M	$ -1.43M
Operating Cash Flow	$ -1.20M	$ -1.20M	$ -2.30M	$ -1.57M	$ -1.45M
Investing Cash Flow	$ -23.06K	$ 665.80K	$ 2.51M	$ -3.32M	$ -9.91M
Financing Cash Flow	$ 1.85M	$ 411.70K	-	-	$ 0.00

Currency in USD

BioRestorative Therapies Earnings and Revenue History

Income Statement >

BioRestorative Therapies Debt to Assets

Balance Sheet >

BioRestorative Therapies Cash Flow

Cash Flow >

BioRestorative Therapies Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing